Skip to content

Author

K. Yakushijin

We have 3 of 272 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Differential impact of GVHD prophylaxis on CMV infection and survival outcomes after cord blood transplantation in the era of letermovir.

Although recent studies suggested an enhanced graft-versus-tumor (GVT) effect with cord blood transplantation (CBT), higher rates of engraftment failure, acute graft-versus-host disease (GVHD), and infections, including cytomegalovirus (CMV), contribute to increased nonrelapse mortality (NRM). Thus, further optimizatio...

Shunto Kawamura, Y. Akahoshi, Hideaki Nakasone et al. · 0 citations
Open access Sep 2026

First-week expansion of activated peripheral B-cell subsets is associated with grade 3 or higher immune-related adverse events after nivolumab plus ipilimumab

First-week expansion of activated peripheral B-cell subsets after nivolumab plus ipilimumab was associated with subsequent severe irAEs, which support future studies of early B-cell monitoring within integrated multimarker assessments of irAE risk.

H. Takakura, Y. Funakoshi, T. Koyama et al. · 0 citations
Open access Apr 2026

LM-QASAS: reference-free identification of antigen-specific sequences from the BCR repertoire using antibody language models

LM-QASAS provides a rapid, high-precision platform for monitoring humoral immunity against emerging threats by mapping sequences into a high-dimensional semantic embedding space, and identifies functionally convergent clusters of sequences that are semantically similar and exhibit transient expansion upon immune stimul...

Genki Masuda, Y. Funakoshi, S. Iizumi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.